We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+6.2%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$9.56B
AUM Growth
+$531M
Cap. Flow
+$49.6M
Cap. Flow %
0.52%
Top 10 Hldgs %
14.04%
Holding
1,755
New
15
Increased
420
Reduced
1,119
Closed
198

Top Sells

Rank Stock Value
1
DOC icon
Healthpeak Properties
DOC
+$48.2M
2
CLC
Clarcor
CLC
+$15.4M
3
AMGN icon
Amgen
AMGN
+$11.3M
4
AAPL icon
Apple
AAPL
+$9.79M
5
NUE icon
Nucor
NUE
+$8.91M

Sector Composition

Rank Sector Weight
1 Financials 15.52%
2 Healthcare 14.53%
3 Technology 12.08%
4 Consumer Staples 11.47%
5 Industrials 10.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SANM icon
1076
Sanmina
SANM
$11.2B
$424K ﹤0.01%
10,455
-3,439
-25% -$133K
AA icon
1077
Alcoa
AA
$11.7B
$421K ﹤0.01%
12,243
+716
+6% +$25.1K
EVR icon
1078
Evercore
EVR
$13.1B
$421K ﹤0.01%
5,408
-1,732
-24% -$134K
FLIR
1079
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$421K ﹤0.01%
11,609
-678
-6% -$24.4K
CNK icon
1080
Cinemark Holdings
CNK
$3.82B
$420K ﹤0.01%
9,468
-1,451
-13% -$61.1K
CRZO
1081
DELISTED
Carrizo Oil & Gas Inc
CRZO
$420K ﹤0.01%
14,649
-2,218
-13% -$72.8K
DST
1082
DELISTED
DST Systems Inc.
DST
$418K ﹤0.01%
6,818
-800
-11% -$46.4K
HNI icon
1083
HNI Corp
HNI
$3B
$417K ﹤0.01%
9,039
-2,692
-23% -$130K
MRVL icon
1084
Marvell Technology
MRVL
$174B
$417K ﹤0.01%
27,321
+75
+0.3% +$1.16K
OMER icon
1085
Omeros
OMER
$709M
$417K ﹤0.01%
27,563
-7,286
-21% -$79.7K
EXP icon
1086
Eagle Materials
EXP
$6.6B
$416K ﹤0.01%
4,286
-593
-12% -$60.4K
GMED icon
1087
Globus Medical
GMED
$10.4B
$415K ﹤0.01%
14,021
-4,147
-23% -$113K
MGNX icon
1088
MacroGenics
MGNX
$235M
$415K ﹤0.01%
22,337
-5,799
-21% -$112K
MSM icon
1089
MSC Industrial Direct
MSM
$7.02B
$415K ﹤0.01%
4,040
-558
-12% -$56.5K
CHMT
1090
DELISTED
Chemtura Corporation
CHMT
$411K ﹤0.01%
12,307
-2,898
-19% -$96.1K
FNSR
1091
DELISTED
Finisar Corp
FNSR
$410K ﹤0.01%
15,003
-4,631
-24% -$142K
CHDN icon
1092
Churchill Downs
CHDN
$6.03B
$409K ﹤0.01%
15,444
-4,764
-24% -$119K
VIAV icon
1093
Viavi Solutions
VIAV
$9.75B
$406K ﹤0.01%
37,829
-9,903
-21% -$96.3K
AVP
1094
DELISTED
Avon Products, Inc.
AVP
$406K ﹤0.01%
92,275
-27,106
-23% -$135K
THO icon
1095
Thor Industries
THO
$3.99B
$405K ﹤0.01%
4,209
-661
-14% -$68.6K
TIME
1096
DELISTED
Time Inc.
TIME
$404K ﹤0.01%
20,886
-6,203
-23% -$118K
BCRX icon
1097
BioCryst Pharmaceuticals
BCRX
$2.37B
$403K ﹤0.01%
47,927
-12,600
-21% -$87.6K
GWB
1098
DELISTED
Great Western Bancorp, Inc.
GWB
$403K ﹤0.01%
9,500
-2,621
-22% -$113K
IPGP icon
1099
IPG Photonics
IPGP
$3.89B
$400K ﹤0.01%
3,317
-445
-12% -$50.4K
ON icon
1100
ON Semiconductor
ON
$33.8B
$399K ﹤0.01%
25,741
+440
+2% +$6.38K

Similar funds

ProShare Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, ProShare Advisors held 1,755 positions worth $9.56B, up 5.9% from $9.03B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

ProShare Advisors's Q1 2017 filing shows 15 new, 420 increased, 1,119 reduced and 198 closed positions. Its largest new stake was Qiagen: 113,675 shares worth $3.49M. The largest sale was Healthpeak Properties, an estimated $48.2M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

  • ProShare Advisors's largest Q1 2017 buy was Qiagen: 113,675 shares worth $3.49M.
  • ProShare Advisors added most to General Dynamics in Q1 2017, an estimated $57.1M increase.
  • ProShare Advisors's biggest Q1 2017 reduction was Healthpeak Properties, cutting an estimated $48.2M.
  • ProShare Advisors fully exited Clarcor in Q1 2017, selling an estimated $15.4M.
  • ProShare Advisors's ten largest holdings make up 14% of its $9.56B portfolio in Q1 2017.
  • ProShare Advisors opened 15 new positions and closed 198 in Q1 2017.
  • ProShare Advisors's portfolio value rose 5.9% quarter-over-quarter to $9.56B.

Based on ProShare Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.